UTRECHT, The Netherlands, March 6, 2025 /PRNewswire/ -- Vitestro, a pioneer in medical robotics, proudly reveals the name of its autonomous blood drawing device: Aletta™, the first autonomous robotic ...

UTRECHT, The Netherlands, Jan. 12, 2026 /PRNewswire/ -- Vitestro, a pioneer in medical robotics advancing automated diagnostic blood collection, today announced the launch of its new corporate website ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The FDA has authorized Vitestro's Aletta system, the first standalone robotic device for ...

Vitestro has raised $70m to advance development and broaden the commercialisation of its autonomous blood-drawing robot. The Dutch company’s oversubscribed Series B financing round saw a mix of ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The FDA has authorized Aletta, a robotic device designed for autonomous blood draws that ...

Vitestro, a Netherlands-based medical robotics company developing autonomous blood-drawing technology, has raised $70 million in an oversubscribed Series B financing round to accelerate development of ...

A new study shows uneven cervical cancer screening across U.S. regions. Here are current Pap and HPV schedules and at-home testing options. A JAMA Network Open study finds that over 1 million U.S.

Vitestro – a pioneer in autonomous robotic venous access and blood drawing – announced the appointment of Bob Gerberich as Chief Commercial Officer for North America. With this role, Gerberich will ...

Add Yahoo as a preferred source to see more of our stories on Google. Close Up Shot Of Hand Of Male Blood Donor With an Attached Catheter. Once a patient consents to having his or her blood drawn by ...